(Q48266852)

10 February 2018

title

The Psoriasis Symptom Diary: development and content validity of a novel patient-reported outcome instrument (English)

1 reference

10 February 2018

author

Bruce E Strober

6

1 reference

10 February 2018

author name string

Mark Lebwohl

1

1 reference

10 February 2018

Andrine R Swensen

2

1 reference

10 February 2018

Judit Nyirady

3

1 reference

10 February 2018

Edward Kim

4

1 reference

10 February 2018

Chad J Gwaltney

5

1 reference

10 February 2018

publication date

4 April 2013

1 reference

10 February 2018

International Journal of Dermatology

published in

1 reference

10 February 2018

volume

53

1 reference

10 February 2018

issue

6

1 reference

10 February 2018

page(s)

714-722

1 reference

10 February 2018

Psoriasis causes as much disability as other major medical diseases

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2012.05798.X

Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2012.05798.X

A 50% reduction in the Psoriasis Area and Severity Index (PASI 50) is a clinically significant endpoint in the assessment of psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2012.05798.X

Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2012.05798.X

Decision points for the initiation of systemic treatment for psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2012.05798.X

Two decades experience of the Psoriasis Disability Index

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2012.05798.X

Why are quality of life instruments not recognized as reference measures in therapeutic trials of chronic skin disorders?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2012.05798.X

Variability of momentary pain predicts recall of weekly pain: a consequence of the peak (or salience) memory heuristic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2012.05798.X

European patient perspectives on the impact of psoriasis: the EUROPSO patient membership survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2012.05798.X

What criteria do patients use when judging the effectiveness of psoriasis management?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2012.05798.X

Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1--eliciting concepts for a new PRO in

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2012.05798.X

Core outcome measures for chronic pain clinical trials: IMMPACT recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2012.05798.X

Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force report: part 2--assessing respondent understanding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2012.05798.X

10.1111/J.1365-4632.2012.05798.X

21 January 2018

Identifiers

DOI

1 reference

10 February 2018

1 reference

10 February 2018